Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Stone Point Capital to Acquire Genex Services from Funds Advised by Apax Partners
Wayne, PA – Feb.
Mitchell
Article
Motor Vehicle Markets Q4 2017
We recap the motor vehicle markets trends from Q4 2017, highlighting the best-selling U.S.
WorkCompWire
Article
WorkCompWire: Jim Harris: Unleashing Powerful Insights Hidden in Your Bill Review Data
In this column, we look at five strategies that sophisticated vendors are deploying to elevate the bill review process to a strategic, data-f
Workers' Comp
Blog
A Look Back at 40 Years
Whether good or bad, most people see turning age 40 as a major milestone.
WorkCompWire
Article
WorkCompWire: Michael Valasek: Ensuring a Quality IME Result: Three Players in the Process
A certain amount of contention has come to surround the independent medical examination (IME) process.
Mitchell
News Release
Pennsylvania SB 936 Advances—Press Conference on Opioids Follows
During a voting meeting on January 23, 2018, the Pennsylvania House Labor and Industry Committee passed out SB 936.